Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Amarin cardiovascular news

    Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Cardiovascular Amarin filed a lawsuit in the U.S. District Court for the Southern District of New York against FDA seeking a judicial declaration that the …

    Published on 5/18/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars Novartis Sandoz Inc. generics unit filed a statement with the U.S. Court of Appeals for the …

    Published on 5/18/2015
  • Calchan neurology news

    Calchan Ltd., London, U.K. Business: Neurology Calchan transitioned from a virtual company and added Brenda Reynolds as CEO, Manjit Rahelu as COO and Zahid Ali as CSO. Reynolds and Rahelu had been with Convergence …

    Published on 5/18/2015
  • Celgene, Hayman Capital Management cancer news

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Hayman Capital Management, Dallas, Texas Business: Cancer Hedge fund manager Kyle Bass filed a second inter partes review (IPR) challenging a patent covering Celgenes Revlimid …

    Published on 5/18/2015
  • Elpidera, Moderna Therapeutics chemistry news

    Elpidera LLC, Cambridge, Mass. Moderna Therapeutics Inc., Cambridge, Mass. Business: Chemistry Moderna launched Elpidera to develop mRNA-based treatments for rare diseases. Greg Licholai, formerly SVP for real-world and…

    Published on 5/18/2015
  • Quest Diagnostics, Institut National de la Sante et de la Recherche Medicale cancer news

    Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Institut National de la Sante et de la Recherche Medicale (INSERM), Paris, France Business: Cancer Quest and INSERM partnered to launch BRCA Share, a datashare …

    Published on 5/18/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. Court of Appeals for the Federal Circuit (CAFC) granted Amgens motion for a preliminary…

    Published on 5/11/2015
  • Beijing Jialin, Pfizer cardiovascular news

    Beijing Jialin Pharmaceutical Co. Ltd., Beijing, China Pfizer Inc. (NYSE:PFE), New York, N.Y. Business: Cardiovascular Chinas Supreme Peoples Court ruled invalid a patent covering crystalline formulations of Pfizers …

    Published on 5/11/2015
  • Eisai, Glenmark neurology news

    Eisai Co. Ltd.(Tokyo:4523), Tokyo, Japan Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296), Mumbai, India Business: Neurology Eisai and Glenmark settled patent litigation relating to Eisais Banzel rufinamide for…

    Published on 5/11/2015
  • Flagship Ventures, AstraZeneca, Bayer, Nestle other news

    Flagship Ventures, Cambridge, Mass. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Bayer AG (Xetra:BAYN), Leverkusen, Germany Nestle S.A. (SIX:NESN), Vevey, Switzerland Business: Other Flagship announced partnerships…

    Published on 5/11/2015
  • GlaxoSmithKline, Viiv Healthcare infectious news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. ViiV Healthcare Ltd., Brentford, U.K. Business: Infectious GlaxoSmithKline said in its 1Q15 earnings announcement that it will retain its holding in ViiV, its HIV-…

    Published on 5/11/2015
  • J&J, New York University pharmaceuticals news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. New York University, New York, N.Y. Business: Pharmaceuticals Johnson & Johnson enlisted the universitys school of medicine to review compassionate use requests made to …

    Published on 5/11/2015
  • Rare Genomics Institute genomics news

    Rare Genomics Institute, Hanover, Md. Business: Genomics The non-profit launched the Amplify Hope Initiative, a study to determine how crowdfunding can promote scientific research to help rare disease patients. The …

    Published on 5/11/2015
  • WuXi PharmaTech biomanufacturing news

    WuXi PharmaTech Inc. (NYSE:WX), Shanghai, China Business: Biomanufacturing WuXi started construction of a biologics manufacturing facility in Wuxi City that will be the largest in China. The company expects to complete …

    Published on 5/11/2015
  • AOP Orphan, Rigi Healthcare AG pharmaceuticals news

    AOP Orphan Pharmaceuticals AG, Vienna, Austria Rigi Healthcare AG, Kuessnacht, Switzerland Business: Pharmaceuticals AOP and Rigi Healthcare created newco Rigi Orphan Inc. USA to in-license, develop and commercialize …

    Published on 5/4/2015
  • Depomed, Actavis neurology news

    Depomed Inc. (NASDAQ:DEPO), Newark, Calif. Actavis plc (NYSE:ACT), Dublin, Ireland Business: Neurology The companies resolved patent litigation related to Depomeds Gralise gabapentin. Under the settlement, Actavis …

    Published on 5/4/2015
  • Medicines Co., Sun Pharmaceutical cardiovascular news

    The Medicines Co. (NASDAQ:MDCO), Parsippany, N.J. Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA), Mumbai, India Business: Cardiovascular The companies resolved patent litigation related to anticoagulant …

    Published on 5/4/2015
  • Pacira neurology news

    Pacira Pharmaceuticals Inc. (NASDAQ:PCRX), Parsippany, N.J. Business: Neurology Pacira said it received a subpoena from the U.S. Department of Justice, U.S. Attorneys Office for the District of New Jersey, requesting …

    Published on 5/4/2015
  • Biogen, Celgene, Pharmacyclics, Hayman Capital Management autoimmune, cancer news

    Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Celgene Corp. (NASDAQ:CELG), Summit, N.J. Pharmacyclics Inc. (NASDAQ:PCYC), Sunnyvale, Calif. Hayman Capital Management, Dallas, Texas Business: Autoimmune, Cancer Hedge fund…

    Published on 4/27/2015
  • Amgen, Novartis biosimilars news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Biosimilars The U.S. District Court for the Northern District of California denied a motion from Amgen …

    Published on 4/20/2015
  • Biogen, Forward Pharma autoimmune news

    Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Forward Pharma A/S (NASDAQ:FWP), Copenhagen, Denmark Business: Autoimmune Forward said the Patent Trials and Appeals Board of the U.S. Patent and Trademark Office (PTO) …

    Published on 4/20/2015
  • Broad Institute, University of California functional genomics news

    Broad Institute of MIT and Harvard, Cambridge, Mass. University of California, Berkeley, Calif. Business: Functional genomics The University of California Berkeley filed a patent interference request with the U.S. …

    Published on 4/20/2015
  • Eisai cancer, neurology, endocrine/metabolic news

    Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Business: Cancer, Neurology, Endocrine/Metabolic Eisais Eisai Inc. U.S. subsidiary plans to cut about 25% of its 1,700-person workforce and will focus on the development of …

    Published on 4/13/2015
  • GeneOne, Inovio, AstraZeneca, Emory University, U.S. Department of Defense, University of Pennsylvania, Vanderbilt University infectious news

    GeneOne Life Science Inc. (KSE:01100), Seoul, South Korea Inovio Pharmaceuticals Inc. (NASDAQ:INO), Blue Bell, Pa. AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Emory University, Atlanta, Ga. U.S. Department of …

    Published on 4/13/2015
  • Otsuka Pharmaceutical neurology news

    Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan Business: Neurology Otsuka filed a suit in the U.S. District Court for the District of Maryland alleging that FDA unlawfully broadened the approved indication for Otsukas …

    Published on 4/13/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993